Search Results 941-950 of 16405 for monoclonal antibody

1. A Study to Determine the Effects of COVID-19 in Cancer Patients - Mayo Clinic

   Eligible treatment types are chemotherapy, immunotherapy, monoclonal antibody therapy (e.g., rituximab, trastuzumab, cetuximab), targeted therapy (e.g. ...

2. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

   (including monoclonal antibodies). 3. Concurrent cytotoxicity chemotherapy, immunotherapy, radioligand therapy, PARP inhibitor, biological therapy or ...

3. Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease - Mayo Clinic News Network

   Vincent Rajkumar, a Mayo Clinic hematologist and researcher, discusses herd immunity, antibodies and how the body works to fight off disease. Dr. Bret Petersen, ...

4. Clinical Trials - Mayo Nephrology Collaborative Group

   Assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 ...

5. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   ... monoclonal antibodies, antibody drug conjugates, radioimmunoconjugates, or T-cell orother cell-based therapies: 4 weeks (2 weeks permissible before the ...

6. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Doctors and departments - Mayo Clinic

   Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)

7. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) - Mayo Clinic

   ... monoclonal antibody approved by the FDA for the treatment of relapsing MS, or (iii) rituximab. Qualifying DMTs include: dimethyl fumarate, diroximel ...

8. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

   We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the ...

9. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   ... monoclonal antibodies. Patients must not have received prior treatment with a VEGFR tyrosine kinase inhibitor. Except for Cohort D (MSS mCRC), patients must ...

10. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

    Prior therapy with monoclonal antibodies or small molecule inhibitors against Vascular endothelial growth factor (VEGF) or VEGF receptors, including Avastin® or ...